[Pharmacokinetics of thiamphenicol. Behavior in a acute and chronic hepatic insufficiency].
D000081:Acetamides / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D002701:Chloramphenicol / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006207:Half-Life; D006493:Heparin / Q000494:pharmacology; D006505:Hepatitis / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008103:Liver Cirrhosis / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism*; D010627:Phenethylamines / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D013450:Sulfones / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D013997:Time Factors
D000081:Acetamides; D000900:Anti-Bacterial Agents; D010627:Phenethylamines; D013450:Sulfones; D002701:Chloramphenicol; D006493:Heparin
Zur Pharmakokinetik von Thiamphenicol. I. Verhalten bei akuter und chronischer Leberinsuffizienz.